BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability
Authors:
- 1 August 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 38 (8) , 1821-1836
Abstract
Objective—: Diabetic macular edema is a major cause of visual impairment. It is caused by blood-retinal barrier breakdown that leads to vascular hyperpermeability. Current therapeutic approaches consist of retinal photocoagulation or targeting VEGF (vascular endothelial growth factor) to limit vascular leakage. However, long-term intravitreal use of anti-VEGFs is associated with potential safety issues, and the identification of alternative regulators of vascular permeability may provide safer therapeutic options. The vascular specific BMP (bone morphogenetic protein) receptor ALK1 (activin-like kinase receptor type I) and its circulating ligand BMP9 have been shown to be potent vascular quiescence factors, but their role in the context of microvascular permeability associated with hyperglycemia has not been evaluated. Approach and Results—: We investigated Alk1 signaling in hyperglycemic endothelial cells and assessed whether BMP9/Alk1 signaling could modulate vascular permeability. We show that high glucose concentrations impair Alk1 signaling, both in cultured endothelial cells and in a streptozotocin model of mouse diabetes mellitus. We observed that Alk1 signaling participates in the maintenance of vascular barrier function, as Alk1 haploinsufficiency worsens the vascular leakage observed in diabetic mice. Conversely, sustained delivery of BMP9 by adenoviral vectors significantly decreased the loss of retinal barrier function in diabetic mice. Mechanistically, we demonstrate that Alk1 signaling prevents VEGF-induced phosphorylation of VE-cadherin and induces the expression of occludin, thus strengthening vascular barrier functions. Conclusions—: From these data, we suggest that by preventing retinal vascular permeability, BMP9 could serve as a novel therapeutic agent for diabetic macular edema.Keywords
This publication has 100 references indexed in Scilit:
- VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAdJournal of Experimental Medicine, 2012
- A practical guide to evaluating colocalization in biological microscopyAmerican Journal of Physiology-Cell Physiology, 2011
- Diabetic eNOS-Knockout Mice Develop Accelerated RetinopathyInvestigative Ophthalmology & Visual Science, 2010
- Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasiaJournal of Clinical Investigation, 2009
- Adherens Junction: Molecular Architecture and RegulationCold Spring Harbor Perspectives in Biology, 2009
- The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological ImplicationsDevelopmental Cell, 2009
- The FGF system has a key role in regulating vascular integrityJournal of Clinical Investigation, 2008
- Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence FactorCirculation Research, 2008
- VE‐cadherin is a critical endothelial regulator of TGF‐β signallingThe EMBO Journal, 2008
- ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2Blood, 2008